Insulin glargine, a long-acting form of insulin, was marketed under the brand name LANTUS. Lantus is indicated for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia. The primary activity of insulin glargine is regulation of glucose metabolism. It lowers blood glucose levels by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. The off-label use of insulin glargine is the treatment type 2 diabetes in children and the treatment of gestational diabetes.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175453
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
||
|
WHO-ATC |
A10AE54
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
||
|
NDF-RT |
N0000004931
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
||
|
NDF-RT |
N0000004931
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
||
|
WHO-ATC |
A10AE04
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
||
|
NDF-RT |
N0000004931
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
||
|
WHO-VATC |
QA10AE04
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C106526
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
160337-95-1
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
INSULIN GLARGINE
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
SUB08196MIG
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
7572
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
7548
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
160337-95-1
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
274783
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | RxNorm | ||
|
CHEMBL1201497
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
M6297
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | Merck Index | ||
|
118984454
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
C47564
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY | |||
|
DB00047
Created by
admin on Mon Oct 21 21:06:28 UTC 2019 , Edited by admin on Mon Oct 21 21:06:28 UTC 2019
|
PRIMARY |
ACTIVE MOIETY